Comprehensive genomic and immune profiling defines immunotherapy treatment in NSCLC patients with low PD-L1 IHC
by Christina Black | Jul 28, 2022
Cancer testis antigen burden: pan-cancer distribution and survival implications
by Christina Black | Apr 10, 2022
Checkpoint coexpression landscape in gastroesophageal adenocarcinoma
by Christina Black | Mar 8, 2022
A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors
by Christina Black | Dec 3, 2021
Follow Us on Twitter
This December, Dr. Sarabjot Pabla joins the speaker lineup for the TIGIT Axis Therapies Digital Summit. His presentation will focus on TIGIT RNA expressions and their impact in precision oncology medicines. Register for the virtual event today: https://bit.ly/3NAKg3S
LABCORP EXPANDS ACCESS TO COMPREHENSIVE GENOMIC TESTING THROUGH NEW LUNG CANCER PROGRAM UTILIZING OmniSeq INSIGHT
https://tinyurl.com/59xf82c6
@OmniSeq
@Labcorp
#oncology
#precisionmedicine